Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-08

Clinical Trial Update: A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating abemaciclib in advanced biliary tract cancer was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Biliary Tract Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-10-08